Anne Lienhart

1.3k total citations
51 papers, 917 citations indexed

About

Anne Lienhart is a scholar working on Hematology, Genetics and Surgery. According to data from OpenAlex, Anne Lienhart has authored 51 papers receiving a total of 917 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Hematology, 13 papers in Genetics and 9 papers in Surgery. Recurrent topics in Anne Lienhart's work include Hemophilia Treatment and Research (38 papers), Blood Coagulation and Thrombosis Mechanisms (21 papers) and Platelet Disorders and Treatments (12 papers). Anne Lienhart is often cited by papers focused on Hemophilia Treatment and Research (38 papers), Blood Coagulation and Thrombosis Mechanisms (21 papers) and Platelet Disorders and Treatments (12 papers). Anne Lienhart collaborates with scholars based in France, United States and Greece. Anne Lienhart's co-authors include Claude Négrier, Yesim Dargaud, Jean‐Claude Bordet, Raed Al Dieri, Suzette Beguı́n, H.C. Hemker, Christine Trzeciak, V. Chamouard, Sandra Le Quellec and Sandrine Meunier and has published in prestigious journals such as Blood, The American Journal of Human Genetics and Anesthesiology.

In The Last Decade

Anne Lienhart

47 papers receiving 900 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Lienhart France 16 817 231 103 83 73 51 917
Jordi Fontcuberta Spain 6 311 0.4× 80 0.3× 227 2.2× 40 0.5× 100 1.4× 7 426
Katcharin Aryurachai Thailand 9 295 0.4× 342 1.5× 48 0.5× 60 0.7× 54 0.7× 13 470
D. RAPSON Canada 8 501 0.6× 86 0.4× 26 0.3× 131 1.6× 92 1.3× 13 582
Larisa Dzirlo Austria 5 240 0.3× 55 0.2× 34 0.3× 35 0.4× 57 0.8× 10 357
Jeanne‐Yvonne Borg France 13 318 0.4× 108 0.5× 74 0.7× 17 0.2× 46 0.6× 19 450
Juraj Sokol Slovakia 12 202 0.2× 46 0.2× 117 1.1× 59 0.7× 153 2.1× 56 385
B. Ravid Israel 8 247 0.3× 119 0.5× 29 0.3× 23 0.3× 56 0.8× 8 334
M. S. C. Robinson United Kingdom 7 222 0.3× 43 0.2× 121 1.2× 70 0.8× 225 3.1× 7 423
Machin United Kingdom 7 223 0.3× 79 0.3× 46 0.4× 70 0.8× 45 0.6× 8 359
Kazuyoshi Fukuda Japan 9 198 0.2× 53 0.2× 13 0.1× 77 0.9× 12 0.2× 18 367

Countries citing papers authored by Anne Lienhart

Since Specialization
Citations

This map shows the geographic impact of Anne Lienhart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Lienhart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Lienhart more than expected).

Fields of papers citing papers by Anne Lienhart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Lienhart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Lienhart. The network helps show where Anne Lienhart may publish in the future.

Co-authorship network of co-authors of Anne Lienhart

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Lienhart. A scholar is included among the top collaborators of Anne Lienhart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Lienhart. Anne Lienhart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dargaud, Yesim, et al.. (2025). Current trends and advances in the management of acquired Hemophilia A. Blood Reviews. 74. 101320–101320.
2.
Nougier, Christophe, et al.. (2025). In vitro combined haemostatic efficacy of emicizumab and extended half‐life factor VIII compounds. Haemophilia. 31(2). 224–230.
3.
Chatron, Nicolas, C. Zawadzki, Anne Lienhart, et al.. (2024). Whole F8 gene sequencing identified pathogenic structural variants in the remaining unsolved patients with severe hemophilia A. Journal of Thrombosis and Haemostasis. 22(6). 1616–1626. 3 indexed citations
4.
Tardy, Brigitte, Hérvè Chambost, Anne Lienhart, et al.. (2024). Relationship between plasma tissue Factor Pathway Inhibitor (TFPI) levels, thrombin generation and clinical risk of bleeding in patients with severe haemophilia A or B. Haemophilia. 30(3). 693–701. 1 indexed citations
5.
Lienhart, Anne, et al.. (2024). Deciphering the circulating microRNA signature of hemophilic arthropathy. Thrombosis Research. 241. 109099–109099. 1 indexed citations
6.
Dargaud, Yesim, Antoine Rauch, Anne Lienhart, et al.. (2023). Modèle hub & spoke en France : organisation des soins et parcours des patients pour la thérapie génique de l’hémophilie. Hématologie. 29(2). 88–106. 3 indexed citations
7.
Dargaud, Yesim, Sandrine Meunier, Sandra Le Quellec, et al.. (2022). Report of surgeries, their outcome and the thrombin generation assay in patients with Factor XI deficiency: A retrospective single‐centre study. Haemophilia. 28(2). 301–307. 5 indexed citations
8.
Lienhart, Anne, et al.. (2021). Haemophilia A patients' medication adherence to prophylaxis with efmoroctocog alfa. Haemophilia. 27(3). e368–e375. 3 indexed citations
9.
Rugeri, Lucia, Marc Fouassier, Anne Lienhart, et al.. (2020). Management of previously untreated patients with severe haemophilia A preferentially treated with recombinant factor VIII products: Two French centres' real‐life experience. Haemophilia. 26(6). e349–e352. 1 indexed citations
10.
Chelle, Pierre, Pauline Damien, Michèle Piot, et al.. (2019). Tissue factor pathway inhibitor is the main determinant of thrombin generation in haemophilic patients. Haemophilia. 25(2). 343–348. 15 indexed citations
11.
12.
Tsiamyrtzis, Panagiotis, et al.. (2014). A comparison of the 12s rule and Bayesian approach for quality control. Blood Coagulation & Fibrinolysis. 25(6). 634–643. 1 indexed citations
13.
Dargaud, Yesim, et al.. (2012). Seventy‐two total knee arthroplasties performed in patients with haemophilia using continuous infusion. Vox Sanguinis. 104(2). 135–143. 32 indexed citations
14.
15.
Nougier, Christophe, et al.. (2010). Impact of quality control matrix effect: application to the calculation of uncertainty of measurement in one-stage clotting factor VIII assay. Blood Coagulation & Fibrinolysis. 21(5). 498–501. 7 indexed citations
16.
Guyen, Olivier, et al.. (2008). Early to mid-term results of total knee arthroplasty in hemophilic knees: a review of 34 cases. SPIRE - Sciences Po Institutional REpository. 1 indexed citations
17.
Lienhart, Anne, et al.. (2008). Determining the adequate number of internal quality control levels: the example of coagulation factor VIII assay. Blood Coagulation & Fibrinolysis. 19(5). 433–437. 6 indexed citations
18.
Beguı́n, Suzette, Anne Lienhart, Raed Al Dieri, et al.. (2005). Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B. Thrombosis and Haemostasis. 93(3). 475–480. 263 indexed citations
19.
Dargaud, Yesim, et al.. (2003). Spontaneous proximal deep vein thrombosis in a patient with severe haemophilia A. Blood Coagulation & Fibrinolysis. 14(4). 407–409. 20 indexed citations
20.
Lienhart, Anne, et al.. (1999). Déficit en facteur VII et chirurgie. Annales Françaises d Anesthésie et de Réanimation. 18(7). 772–775. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jordi Fontcuberta Breakdown of academic impact, for papers by Katcharin Aryurachai Breakdown of academic impact, for papers by D. RAPSON Breakdown of academic impact, for papers by Larisa Dzirlo Breakdown of academic impact, for papers by Jeanne‐Yvonne Borg Breakdown of academic impact, for papers by Juraj Sokol Breakdown of academic impact, for papers by B. Ravid Breakdown of academic impact, for papers by M. S. C. Robinson Breakdown of academic impact, for papers by Machin Breakdown of academic impact, for papers by Kazuyoshi Fukuda
Rankless by CCL
2026